0001209191-19-035639.txt : 20190607 0001209191-19-035639.hdr.sgml : 20190607 20190607175816 ACCESSION NUMBER: 0001209191-19-035639 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190606 FILED AS OF DATE: 20190607 DATE AS OF CHANGE: 20190607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBINSON LOWELL W CENTRAL INDEX KEY: 0001244216 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35952 FILM NUMBER: 19887074 MAIL ADDRESS: STREET 1: 470 WEST END AVENUE CITY: NEW YORK STATE: NY ZIP: 10024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383826477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 CITY: LEAWOOD STATE: KS ZIP: 66211 BUSINESS PHONE: 913.353.1000 MAIL ADDRESS: STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 CITY: LEAWOOD STATE: KS ZIP: 66211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-06 0 0001509190 ARATANA THERAPEUTICS, INC. PETX 0001244216 ROBINSON LOWELL W C/O ARATANA THERAPEUTICS, INC. 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 1 0 0 0 Common Stock 2019-06-06 4 A 0 4500 0.00 A 4500 D Stock Option (Right to Buy) 4.80 2019-06-06 4 A 0 7500 0.00 A 2029-06-05 Common Stock 7500 7500 D Vests on the earlier of (i) the first anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's next annual meeting of stockholders following the date of grant, subject to continued service as a member of the Board of Directors of the Issuer through such vesting date. The transactions reported in this Form 4 consist of annual equity awards issued pursuant to the Issuer's Non-Employee Director Compensation Program, filed as Exhibit 10.2 to the Issuer's Form 10-Q dated August 5, 2016. /s/ John C. Ayres, Attorney-in-Fact for Lowell W. Robinson 2019-06-07